This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Lymphoproliferative Disorders
Information about Lymphoproliferative Disorders: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Lymphoproliferative Disorders
Most recent studies have shown that Lymphoproliferative Disorders shares some biological mechanisms with autoimmune-diseases, autoimmune-reaction, b-cell-lymphomas, chronic-lymphocytic-leukemia, decreased-immunologic-activity-[pe], epstein-barr-virus-infections, hodgkin-disease, hyperplasia, immunologic-deficiency-syndromes, infective-disorder, leukemia, lymphoid-leukemia, lymphoma, lymphoma-non-hodgkin, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasms, post-transplant-lymphoproliferative-disorder, t-cell-lymphoma, virus-diseases.
Among the many pathways, these few ones have gauged particular interests from scientists studying Lymphoproliferative Disorders, and have been seen in publications frequently: B Cell Proliferation, Cell Activation, Cell Cycle, Cell Death, Cell Development, Cell Differentiation, Cell Growth, Cell Proliferation, Cytokine Production, Hypersensitivity, Immune Response, Localization, Lymphocyte Activation, Lymphocyte Proliferation, Oncogenesis, Pathogenesis, Programmed Cell Death, Secretion, T Cell Activation, T Cell Proliferation
Quite a number of genes have been found to play important roles in Lymphoproliferative Disorders, such as APCS, BCL2, CD19, CD4, CD5, CD8A, CTLA4, FAS, HLA-DQA1, IL10, IL2, IL6, KRT20, MS4A1, NOD2, PTPRC, SH2D1A, TNF, TNFRSF8. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.